Small molecule SMU-CX24 targeting toll-like receptor 3 counteracts inflammation: A novel approach to atherosclerosis therapyXiaohong Cen, Kui Cheng, Yuqing Liang et al.|Acta Pharmaceutica Sinica B|2022Cited by 28